pay $26 billion to settle with all but five of the states suing them. Had the states gone to court, the companies could have faced up to $95 billion in penalties. Illegal distribution On October 1 2018, Amerisourcebergen agreed to pay $625M to resolve allegations that it had illegally repackaged and distributed oncology-supportive injectable drugs. In October 2018, AmerisourceBergen agreed to pay $625 million to settle civil fraud allegations resulting from its repackaging and sale of adulterated drugs and unapproved new drugs, double billing and providing kickbacks to physicians. AmerisourceBergen's stock price reportedly plummeted after they were among other drug distributors who offered $10 billion to settle their portion of the national opioids lawsuit. States countered with $45 billion. References External links Companies based in Chester County, Pennsylvania Companies listed on the New York Stock Exchange Pharmaceutical companies established in 2001 Pharmaceutical companies of the United States American companies established in 2001 Companies based in Philadelphia Health care companies based in Pennsylvania